Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 7;19(10):37.
doi: 10.1007/s11908-017-0588-3.

Primary HIV Infection: Clinical Presentation, Testing, and Treatment

Aurélia Henn  1   2 , Clara Flateau  1 , Sébastien Gallien  3   4
Affiliations
Review

Primary HIV Infection: Clinical Presentation, Testing, and Treatment

Aurélia Henn et al. Curr Infect Dis Rep. .

Abstract

Purpose of review: The purpose of this review was to provide current data on clinical presentation, diagnosis, and treatment of primary HIV infection (PHI).

Recent findings: In 65 to 95% of cases, PHI causes acute retroviral syndrome presenting with unspecific flu-like symptoms. Symptomatic PHI was associated with a faster clinical and immunological progression of HIV infection. Point-of-care tests remain less sensitive than fourth-generation immunoassays (IA) in PHI, especially after tenofovir-based prophylaxis use. Early antiretroviral treatment (ART) started during PHI prevents HIV transmission and decreases viral and immunological reservoir constitution. Recommended ART regimens in PHI are combinations of tenofovir and emtricitabine with either darunavir/ritonavir, or dolutegravir. Starting ART the earliest is highly recommended for clinical, virological, immunological, and public health benefits. Reducing HIV reservoir constitution in PHI may optimize potential opportunities for future functional cure.

Keywords: Acute retroviral syndrome; Antiretroviral treatment; Fiebig stages; HIV diagnosis; Point-of-care tests; Primary HIV infection.

PubMed Disclaimer

References

    1. J Int AIDS Soc. 2015 May 07;18:19470 - PubMed
    1. J Clin Virol. 2013 Dec;58 Suppl 1:e119-22 - PubMed
    1. J Antimicrob Chemother. 2013 May;68(5):1169-78 - PubMed
    1. PLoS Med. 2012;9(3):e1001196 - PubMed
    1. N Engl J Med. 2011 May 19;364(20):1943-54 - PubMed

LinkOut - more resources